AAPKI VENTURES INC. CORPORATE UPDATE Surrey, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Aapki Ventures Inc. ("AAPKI" or the "Company") (CSE: APKI) (FFT: 64Q), announces that Parmjeet Johal has resigned from the Board of the...

AAPKI Ventures Inc. Announces Debenture Financing Surrey, BC, March 18, 2024 (GLOBE NEWSWIRE) -- AAPKI Ventures Inc., formerly Pushfor Tech Inc. ("AAPKI" or the "Company") (CSE: APKI) (FFT: 64Q), is pleased to announce its intention to conduct a...

NYSE: AAP LONG TERM Investor Alert: Lawsuit against certain directors of Advance Auto Parts, Inc. (NYSE: AAP) announced by the Shareholders Foundation A lawsuit was filed by two NYSE:AAP investors against certain Advance Auto Parts directors. NYSE: AAP investors should contact the Shareholders Foundation

Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice XHANCE significantly reduced both symptoms and sinus opacification in participants with chronic sinusitis (chronic rhinosinusitis) in two randomized controlled Phase 3 Clinical Trials (ReOpen1 and...